He Went to Prison for Gene-Editing Babies. Now He's Planning to Do It Again Chinese scientist He Jiankui wants to end Alzheimer's and thinks Silicon Valley is conducting a "Nazi eugenic experiment." In 2018, a nervous-looking He Jiankui took the stage at a scientific conference in Hong Kong. A hush settled over the packed auditorium as the soft-spoken Chinese scientist adjusted his microphone and confirmed the circulating media reports: He had created the world's first gene-edited babies . Three little girls were born with modifications to their genomes that were intended to protect them against HIV. The changes he'd made to their DNA were permanent and heritable, meaning they could be passed down to future generations.

There are nearly seven million people currently diagnosed with Alzheimer's in the US, and while there is no cure, experts are searching for ways to prevent it. That is because stories about far off lands and mythical creatures require readers to remember what happened early on in the book to understand the ending. 'Fiction may elicit more intense emotions and imagery in addition to new facts and ideas from reading non-fiction books,' said Dr. Zaldy Tan, a professor of neurology and medicine at Cedars-Sinai Medical Center. 'But more than the type of book, the key here is sustainability, Tan said, adding: 'I recommend people challenge their minds by reading something new to them.' Alzheimer's disease is the sixth leading cause of death in the US with 6.9 million people living with the disease which is expected to double by 2050 Neuroscientists have suggested that remaining physically active and engaging in other activities like knitting, playing chess and puzzles and gardening could also prevent cognitive decline. 'Leisure activities including reading have been associated with lower risk of developing dementia in older adults,' Tan told DailyMail.com.

AI brain mapping with EEG discovered Alzheimer's brainwave and could detect preclinical Alzheimer's dementia(AD). This has been enabled by an innovative AI technology of iMediSync in brain mapping. With AI analytics and brain mapping techniques, they also serve personalized NIR-LED neuromodulation using their upcoming novel headset, iSyncWave to enhance neuronal activity. These preclinical phenomena are difficult to detect just by inspection. But Artificial Intelligence(AI) technology can do this by deep learning.

The growing use of artificial intelligence has the potential to transform the care and outcomes of complex diseases."

RALEIGH – A startup in Raleigh backed by investor and Sprout Pharmaceuticals CEO Cindy Eckert, is unveiling Thursday a different approach to dealing with Alzheimer's that is powered by artificial intelligence, not drugs. And its solution is part of a new effort launched by the Women's Alzheimer's Movement Prevention Center at Cleveland Clinic, an internationally respected medical institution. ExtND is among the offerings from the Women's Alzheimer's center, which also was unveiled today in Las Vegas, according to a spokesperson for uMETHOD. Several medical institutions already are deploying the method. More than 5 million people are currently afflicted with Alzheimer's and the disease is the sixth leading cause of death in the US, according to the Alzheimer's Assocation.